Navigation Links
Medivir Completes Previously Announced Oncology Programs Acquisition
Date:12/29/2016

STOCKHOLM, Sweden, Dec 29, 2016 /PRNewswire/ --

Medivir AB (Nasdaq Stockholm: MVIR) today announces that the acquisitions of the two clinical stage oncology programs from TetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG) have been completed.

In connection with the closing, Medivir has paid the upfront payment of US$12M to TetraLogic.

Medivir will be holding an investor call on January 9, 2017 to present further financial aspects of the acquired programs including the clinical stage compounds remetinostat and birinapant.

The information on the conference call and webcast appear below:

INVITATION TO CONFERENCE CALL AND WEBCAST
Medivir will be conducting an analyst and investor conference call/webcast on 9 January, at 15.00 CET.

Niklas Prager CEO, Ola Burmark CFO and Richard Bethell CSO will be presenting and will be available for questions.

To join the conference call, please dial:
Sweden +46 (0)8 566 426 62
Europe +44(0)20 300 898 02
USA +1 855 753 22 35  

The webcast can be accessed on the website: www.medivir.com

For further information, please contact:
Niklas Prager, CEO and President Medivir AB, +46 8 407 6430
Richard Bethell, CSO Medivir AB, mobile +46 (0)72-704 3211
Ola Burmark, CFO Medivir AB, mobile: +46 (0) 725 480 580

About Medivir
Medivir is a research based pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Medivir's class B share is listed on the Nasdaq Stockholm Mid Cap List.

CONTACT:

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/medivir/r/medivir-completes-previously-announced-oncology-programs-acquisition,c2157886

The following files are available for download:

http://mb.cision.com/Main/652/2157886/609185.pdf

Press release (PDF)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medivir-completes-previously-announced-oncology-programs-acquisition-300384009.html


'/>"/>
SOURCE Medivir
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Current Hepatitis C Virus Regimens to Face Stiff Competition with the Launch of Gileads Sofosbuvir and Janssen/Medivirs Simeprevir
2. MSD Completes Merger with First Choice Medical Supply
3. Henry Schein Completes Investment With Full-Service Dental Distributor Marrodent
4. Arena Pharmaceuticals Completes Enrollment in Ralinepag Phase 2 Clinical Trial for Pulmonary Arterial Hypertension (PAH)
5. Maxor Completes Its Acquisition of Pharmaceutical Specialties, Inc. (PSI)
6. Neurotrope Completes Enrollment in its Randomized, Double-Blinded, Placebo-Controlled Phase 2 Clinical Trial of Bryostatin in Patients With Moderate to Severe Alzheimers Disease
7. Amarantus Completes Sale of Diagnostics Division, Announces Fiscal Year 2015 and First Quarter 2016 Financial Results
8. Diplomat Completes Acquisition of TNH Advanced Specialty Pharmacy
9. Impulse Dynamics Completes $30 Million Financing Round
10. Rx-360 Completes Training Workshops in Africa Covering Good Distribution Practices
11. Valeritas Completes Alternative Public Offering and Raises Gross Proceeds of $25.2 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... August 27, 2020 , ... InfoMC, a ... successful completion of their 2020 System and Organizational Controls (SOC) 1® Type 2 ... and MARS-E compliance assessment. These achievements reflect their long-standing commitment to privacy, security, ...
(Date:8/27/2020)... ... August 27, 2020 , ... Bridge To A Cure Foundation announces ... an adult and pediatric neuro-oncologist who serves on the Board of Directors at The ... Duke University Medical School. , Internationally recognized, Dr. Friedman is a widely published author ...
(Date:8/26/2020)... ... 26, 2020 , ... Unscrupulous sellers across the country are ... purification technologies, including GreenTech Environmental’s proprietary methods, have been used successfully to curb ... has published results of singular and scientific testing against the coronavirus. , As ...
Breaking Medicine Technology:
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... As fall ... side”, the Cohn Health Institute has taken this time to expand and ... of its 30th Anniversary, the Cohn Health Institute will be relaunching its brand new ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, ... masks to medical first responders across the United States. Since the start of ... protective equipment (PPE) medical centers , hospitals , firefighters , ...
(Date:8/31/2020)... ... August 31, 2020 , ... The pandemic and topsy-turvy economic outlook continues to put ... and look for ways to trim the fat from our monthly expenses and put more ... it’s also important that you have a financial safety net in place in case something ...
(Date:8/29/2020)... , ... August 29, 2020 , ... When professor and ... with greater ease than most people would. Rather than become melancholic, however, he put ... advice on achieving one’s dreams. Randy Pausch took a negative situation and turned it ...
(Date:8/28/2020)... ... August 28, 2020 , ... Integrated Viral Protection (IVP Air) today ... to deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is the first ... plans to fully reopen equipped with the filtration system on September 8th. , ...
Breaking Medicine News(10 mins):